Also available in Persian — نسخه فارسی EN فا
❓ Unknown

Secretary of the Kidney Transplant Scientific Association: Halting Import of Medication for Transplant Patients Puts Them at Risk of Organ Rejection

Jan 23, 2026 January 23, 2026 1 min read 📰 Iran International (Farsi)
📋 Key Takeaway

A kidney transplant patient reported a critical shortage of Myfortic, a medication essential for preventing organ rejection. Pharmacies are out of stock, forcing patients to look for alternatives. This situation poses a significant risk to the health of transplant patients in Iran.

🔍 Quick Context Guide
💡 Bottom Line: The unavailability of Myfortic puts kidney transplant patients at serious risk, underscoring critical healthcare supply issues in Iran.

👥 Key Players

Kidney Transplant Scientific Association MENTIONED
Medical organization overseeing transplant practices
"They play a crucial role in ensuring the health and safety of transplant patients in Iran."
Transplant Patients MENTIONED
Individuals affected by the medication shortage
"Their health and well-being depend on access to essential medications to prevent organ rejection."

📰 What Happened

There is a critical shortage of Myfortic, a medication necessary for kidney transplant patients to prevent organ rejection. Patients are now unable to find this medication in pharmacies and are being forced to seek alternatives.

  • Myfortic is essential for preventing organ rejection in kidney transplant patients.
  • Pharmacies across Iran have reported a complete stockout of this medication.

💡 Why It Matters

🇮🇷 For Iran: The shortage of Myfortic poses a direct threat to the health of transplant patients, highlighting systemic issues in Iran's healthcare supply chain.
🌍 Regional: This situation may raise concerns about healthcare stability in the region, especially in countries facing similar economic challenges.
🌐 International: The inability to supply essential medications reflects broader issues related to sanctions and healthcare access in Iran, which may affect international perceptions.

📚 Background

Iran has faced significant challenges in its healthcare system, particularly in accessing medications due to economic sanctions and domestic production limitations. Kidney transplants require strict medication regimens to prevent organ rejection.

Healthcare in Iran Impact of sanctions on Iranian medicine
📡 Source: NEUTRAL
📊 Confidence: 70%
ILNA is a news agency that aims to provide accurate reporting but may reflect the challenges faced by the Iranian healthcare system.

A kidney transplant patient told ILNA news agency that the supply of Myfortic, a medication used to prevent organ rejection in transplant patients, has been decreasing in recent months and is now "completely unavailable." According to him, pharmacies have announced that their stock has run out, and patients must seek alternative medications.

🌐

Translated from the original and edited for English readers. View original source →

Translation confidence: 85%

📰 Related Coverage

⚖️ Independent Platform — Artesh.com is not affiliated with any government, military, or political organization. Editorial Policy →